Publication Profile
Orcid
Educational Details
Dr. Amal Shouair earned her Bachelor of Pharmacy with an excellence degree with honors from Alexandria University in 2006. She later completed a Diploma in Clinical Pharmacy from the same institution. She is currently a Master’s researcher in Microbiology and Immunity and has pursued postgraduate studies in Clinical Research at Harvard Medical School, where she is an alumnus of the ECSRT scholarship program. Dr. Shouair has also undertaken specialized training in leadership in medicine at Harvard Medical School and completed a professional government official program at the National Training Academy. Additionally, she was recognized among the top 10 participants in Egypt’s TOT program at Princess Fatma Academy.
Professional Experience
Dr. Amal Shouair serves as the Deputy Manager at Kafer Eldwar General Hospital and holds multiple key positions, including Head of the Clinical Pharmacy Unit and Head of the Training Department since 2016. She is also a Clinical Research Department Coordinator and an official Clinical Pharmacy Trainer for the Egyptian Fellowship Program.
Her experience includes supervising and lecturing in summer training programs for third-year pharmacy students at Alexandria University, serving as a Clinical Pharmacy and Pharmaceutical Care Lecturer, and acting as a Medical Club Coordinator at her hospital. She has been actively involved in educational programs on COVID-19 protocols, training over 400 medical staff members.
Dr. Shouair has also contributed to nursing education, focusing on safe medication use in critical care departments, and has developed and implemented several antibiotic stewardship programs, particularly in neonatal intensive care units (NICU), improving patient care while optimizing antimicrobial use. She has played a significant role in the “Drug Misuse Crisis” awareness campaign under the Elbehira Health Directorate, delivering lectures on antibiotic misuse and resistance across healthcare institutions.
Additionally, she has taken part in hospital administration, infection control, and strategic planning initiatives, with training in Total Quality Management (TQM), crisis management, pharmacoeconomics, and antimicrobial stewardship programs.
Research Interest
Dr. Shouair’s research interests focus on clinical pharmacy, antimicrobial resistance, pharmacoeconomics, neonatology, and infectious diseases. She has led NICU-based studies on antibiotic protocols, contributing to improved neonatal care. Her work includes statistical studies on antimicrobial resistance in NICU departments, research on the effect of vitamin K supplementation in neonates receiving prolonged antibiotic therapy, and investigations into the role of anti-interleukin-6 in reducing COVID-19 mortality rates.
Her project on reducing Linezolid use was among the top 15 projects selected from 100 hospitals by the Egyptian Drug Authority.
Author Metrics
Dr. Shouair has authored and co-authored several research studies and clinical protocols, with her work focusing on antibiotic stewardship, NICU care, and COVID-19 treatment strategies. Her contributions in pharmacoeconomics and antimicrobial resistance have been recognized in hospital and governmental healthcare settings, making a significant impact on patient safety and cost-effective treatment strategies.
Conclusion
Dr. Amal Shouair is a highly suitable candidate for the Best Researcher Award in the field of Toxicology and Clinical Pharmacy. Her work in antimicrobial resistance, neonatology, and pharmacoeconomics has made a substantial impact on healthcare policies and hospital protocols. With additional focus on international collaborations and publications, she could further strengthen her standing as a global leader in clinical research.